Edwards Lifesciences Corporation (EW ), the global leader in the science of heart valves and hemodynamic monitoring, announced that new data from the European multi-center TRITON trial studying the EDWARDS INTUITY valve system highlights the promise of several important benefits, including the facilitation of small-incision surgery for aortic valve replacement (AVR), a high procedural success rate, and consistent and sustained hemodynamic valve performance at one year. The data were presented today during the Emerging Technologies and Techniques Forum at the American Association for Thoracic Surgery s 92nd Annual Meeting in San Francisco.
There is a causal link between increased body mass index (BMI) and the risk for ischemic heart disease, according to a new study.
Patients with implantable defibrillators (ICDs) or resynchronization devices with defibrillator (CRT-Ds) were most likely to die of heart failure or noncardiac causes, not sudden death, a single-center study found.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today released its bi-annual product performance report (PPR) on its website, sjmprofessional.com. The PPR updates the performance of all the company’s cardiac rhythm management devices, including actively-monitored registry data that supports the safety and reliability of the current-generation Durata® lead with Optim® insulation. The report also provides a new, expanded analysis specifically addressing the performance of the company’s high-voltage leads.
A year after J&J announced the biggest acquisition in its 126-year history, newly appointed Chief Executive Officer Alex Gorsky is now looking to takeovers to bolster the medical-device unit with products such as heart valves, according to an interview last week with Bloomberg News. J&J’s own cardiovascular sales have fallen for five straight years, the only business in its medical device division to shrink.
Transaortic valve replacement (TAVI) boosts quality of life rapidly with sustained benefits over the mid term, researchers found in real-world practice.
TAVR: transforming the traetment of Aortic Stenosis
IF YOU COULD SEE ME NOW: Medication Adherence Reimagined
Continuing oral anticoagulation when undergoing implantation of a cardiac device appears to minimize the bleeding risk compared with a heparin bridging strategy, a meta-analysis showed.
El flujo sanguíneo al corazón aumenta en los hombres cuando experimentan estrés mental, pero no cambia en las mujeres, sugiere un estudio reciente de tamaño reducido. El hallazgo podría explicar por qué las mujeres son más propensas que los hombres a tener problemas cardiacos cuando experimentan distrés emocional, señalaron investigadores del Colegio de Medicina de la Universidad Estatal de Pensilvania.
GAITHERSBURG, Md. -- An FDA advisory committee has voted 7-1 to recommend approval for a novel subcutaneous implantable cardioverter defibrillator (ICD).
Cuando los pacientes de fibrilación auricular dejan de tomar anticoagulantes, su riesgo de accidente cerebrovascular (ACV) aumenta rápidamente, halla una investigación reciente. Ese riesgo aumenta a más o menos el mismo nivel ya sea que tomen warfarina o un medicamento más reciente y costoso llamado Xarelto (rivaroxabán).
Nueva evidencia sugiere que un tipo de afección de hiperactividad tiroidea parece fomentar el riesgo de problemas cardiacos, sobre todo fibrilación auricular (una forma de latido cardiaco irregular) y muerte prematura.
Recently FDA-Approved, Novel Heart Device Shows Consistently Low Event Rates Across Broad Spectrum of Coronary Artery Disease Patients, Including Those with Diabetes
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos